INS and diabetes mellitus: Restoring insulin function in the brain via intranasal insulin is now being tested as a potential therapeutic option for neurocognitive dysfunction in both diabetes and dementia separately (Claxtonet al., 2015;Novaket al., 2014) and repurposing diabetes drugs for use in dementia has also been proposed (Yarchoan & Arnold, 2014).